Johanna Sillman
Rotkreuz, ZG, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Analytical and clinical performance of the updated Elecsys Anti-TPO II assay for the detection of antibodies against thyroid peroxidase to aid in the diagnosis of autoimmune thyroid diseases.
Journal: Clinical chemistry and laboratory medicine
Published: January 09, 2026
Evaluating the PCOS risk algorithm (PriskA): a pilot study.
Journal: Journal of ovarian research
Published: September 19, 2025
Economic impact of the Elecsys anti-Müllerian hormone Plus immunoassay for anti-Müllerian hormone testing as part of polycystic ovary syndrome assessment in the United Kingdom.
Journal: PloS one
Published: February 17, 2025
Validation of an Anti-Müllerian Hormone Cutoff for Polycystic Ovarian Morphology in the Diagnosis of Polycystic Ovary Syndrome in the HARMONIA Study: Protocol for a Prospective, Noninterventional Study.
Journal: JMIR research protocols
Published: May 09, 2023
Clinical utility of sFlt-1 and PlGF in screening, prediction, diagnosis and monitoring of pre-eclampsia and fetal growth restriction.
Journal: Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology
Published: December 20, 2021
Antimüllerian hormone to determine polycystic ovarian morphology.
Journal: Fertility and sterility
Published: November 12, 2020
Gestational Age-Specific Reference Ranges for the sFlt-1/PlGF Immunoassay Ratio in Twin Pregnancies.
Gestational Age-Specific Reference Ranges for the sFlt-1/PlGF Immunoassay Ratio in Twin Pregnancies.
Journal: Fetal diagnosis and therapy
Published: February 26, 2020
Elecsys® and Kryptor immunoassays for the measurement of sFlt-1 and PlGF to aid preeclampsia diagnosis: are they comparable?
Journal: Clinical chemistry and laboratory medicine
Published: November 16, 2018
Showing 1-8 of 8
Last Updated: 09/26/2026